Speaking Engagement

Understanding the EU AI Act

October 30, 2024

Foley Hoag partner Christopher Escobedo Hart, Co-Chair of the firm's Privacy & Data Security Practice, will speak as part of a panel discussion on "Understanding the EU AI Act: Insights From All Stakeholders in Clinical Trials, From Emerging to Large Pharma" during the 2024 Summit for Clinical Ops Executives.

The EU AI act is set to shake-up the entire European tech sector. Biotechs, in particular, are concerned about the key steps they must take in order to comply. Currently, there are two conflicting opinions regarding the Act—naturally on one end some are worried regulation will stifle innovation in Europe. On the other end, some are worried the Act does not go far enough. Chris and his fellow panelists will explore the steps required to comply with the act, the day-to-day operational changes these steps will induce, the potential long-term impacts and how founders and executives can de-risk the entire process.